PT
PTC Therapeutics
PTCT · NASDAQ
$68.81 +1.90% (+$1.28)
1M -7.14%
Market Cap $5.74B
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$93.48
35.9% upside
Trenutna cena
$68.81
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PTCT trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
8 /100
Expensive EV/EBITDA 31.06x
P/S 5.69x
P/E N/A
Growth
100 /100
Growing Rev. growth 35.30%
EPS growth N/A
FCF growth N/A
Profitability
34 /100
Moderate Gross margin 82.14%
Net margin 3.80%
Op. margin 11.52%
Quality
11 /100
Poor ROIC 2.61%
ROA 1.18%
Asset turnover 0.31x
Debt
74 /100
Low Current ratio 3.39x
Int. coverage 0.64x
Net debt/EBITDA -2.04x
Stability
25 /100
Unstable Beta 0.55x
Rev. volatility 64.91%
EPS volatility 144.56%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PTCT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Matthew Klein
Employees
991
Headquarters
Warren
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report